U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C13H17N3O2
Molecular Weight 247.293
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PARBENDAZOLE

SMILES

CCCCC1=CC=C2N=C(NC(=O)OC)NC2=C1

InChI

InChIKey=YRWLZFXJFBZBEY-UHFFFAOYSA-N
InChI=1S/C13H17N3O2/c1-3-4-5-9-6-7-10-11(8-9)15-12(14-10)16-13(17)18-2/h6-8H,3-5H2,1-2H3,(H2,14,15,16,17)

HIDE SMILES / InChI

Description

Parbendazole is a potent inhibitor of microtubule assembly that was studied as an anthelmintic agent. Information about the current use of this drug is not available.

Approval Year

Unknown
139594
Targets

Targets

Primary TargetPharmacologyConditionPotency
Inhibitor
8297
PubMed

PubMed

TitleDatePubMed
In vitro susceptibilities of the AIDS-associated microsporidian Encephalitozoon intestinalis to albendazole, its sulfoxide metabolite, and 12 additional benzimidazole derivatives.
1997 Dec
Parbendazole.
2010
Name Type Language
PARBENDAZOLE
INN   MI   USAN   USP-RS  
INN   USAN  
Official Name English
SK&F-29044
Code English
SK&F 29044
Code English
PARBENDAZOLE [USP-RS]
Common Name English
TCMDC-131798
Code English
NSC-256420
Code English
PARBENDAZOLE [USAN]
Common Name English
CARBAMIC ACID, (5-BUTYL-1H-BENZIMIDAZOL-2-YL)-, METHYL ESTER
Common Name English
PARBENDAZOLE [MI]
Common Name English
parbendazole [INN]
Common Name English
Methyl 5-butyl-2-benzimidazolecarbamate
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C250
Created by admin on Fri Dec 15 15:21:44 GMT 2023 , Edited by admin on Fri Dec 15 15:21:44 GMT 2023
WHO-VATC QP52AC03
Created by admin on Fri Dec 15 15:21:45 GMT 2023 , Edited by admin on Fri Dec 15 15:21:45 GMT 2023
Code System Code Type Description
EPA CompTox
DTXSID0045410
Created by admin on Fri Dec 15 15:21:44 GMT 2023 , Edited by admin on Fri Dec 15 15:21:44 GMT 2023
PRIMARY
ECHA (EC/EINECS)
238-133-3
Created by admin on Fri Dec 15 15:21:44 GMT 2023 , Edited by admin on Fri Dec 15 15:21:44 GMT 2023
PRIMARY
EVMPD
SUB09620MIG
Created by admin on Fri Dec 15 15:21:44 GMT 2023 , Edited by admin on Fri Dec 15 15:21:44 GMT 2023
PRIMARY
CAS
14255-87-9
Created by admin on Fri Dec 15 15:21:44 GMT 2023 , Edited by admin on Fri Dec 15 15:21:44 GMT 2023
PRIMARY
MESH
C100292
Created by admin on Fri Dec 15 15:21:44 GMT 2023 , Edited by admin on Fri Dec 15 15:21:44 GMT 2023
PRIMARY
FDA UNII
N4X8WVX2UG
Created by admin on Fri Dec 15 15:21:44 GMT 2023 , Edited by admin on Fri Dec 15 15:21:44 GMT 2023
PRIMARY
SMS_ID
100000082794
Created by admin on Fri Dec 15 15:21:45 GMT 2023 , Edited by admin on Fri Dec 15 15:21:45 GMT 2023
PRIMARY
NCI_THESAURUS
C96752
Created by admin on Fri Dec 15 15:21:44 GMT 2023 , Edited by admin on Fri Dec 15 15:21:44 GMT 2023
PRIMARY
INN
2503
Created by admin on Fri Dec 15 15:21:44 GMT 2023 , Edited by admin on Fri Dec 15 15:21:44 GMT 2023
PRIMARY
RS_ITEM_NUM
1498706
Created by admin on Fri Dec 15 15:21:44 GMT 2023 , Edited by admin on Fri Dec 15 15:21:44 GMT 2023
PRIMARY
PUBCHEM
26596
Created by admin on Fri Dec 15 15:21:44 GMT 2023 , Edited by admin on Fri Dec 15 15:21:44 GMT 2023
PRIMARY
ChEMBL
CHEMBL528271
Created by admin on Fri Dec 15 15:21:44 GMT 2023 , Edited by admin on Fri Dec 15 15:21:44 GMT 2023
PRIMARY
MERCK INDEX
m8409
Created by admin on Fri Dec 15 15:21:44 GMT 2023 , Edited by admin on Fri Dec 15 15:21:44 GMT 2023
PRIMARY Merck Index
NSC
256420
Created by admin on Fri Dec 15 15:21:44 GMT 2023 , Edited by admin on Fri Dec 15 15:21:44 GMT 2023
PRIMARY
ACTIVE MOIETY
Structure of PARBENDAZOLE
SALT/SOLVATE (PARENT)
Structure of PARBENDAZOLE HYDROCHLORIDE
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966